Somatization disorder: A practical review

Canadian Journal of Psychiatry

Volumn 49, Issue 10, 2004, Pages 652-662

  Mai, François ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Social Development Canada   (Canada)

^c Tower B   (Canada)

Author keywords

Briquet's syndrome; Conversion; Hysteria; Somatization; Somatization disorder

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HEALTH CARE SYSTEM; HEALTH CENTER; HEREDITY; HUMAN; LIFE EVENT; MEDICAL EDUCATION; MEDICAL LITERATURE; MENTAL DISEASE; MENTAL STRESS; META ANALYSIS; OUTCOMES RESEARCH; PERSONALITY; PHOBIA; PREVALENCE; PSYCHIATRIST; PSYCHOTHERAPY; RELAXATION TRAINING; REVIEW; SIDE EFFECT; SOCIAL PSYCHOLOGY; SOMATIZATION; SYSTEMATIC REVIEW; TRAINING;

EID: 8744253681     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370404901002     Document Type: Review

References (90)

1. Marin C, Carron R. The origin of the concept of somatization. Psychosomatics 2002;43:249-50.
2. American Psychiatric Association. Diagnostic and statistical manual of psychiatric disorders. 3rd ed. Washington (DC): American Psychiatric Association; 1980.
3. Briquet P. Traité de l'hystérie. Paris: Baillière; 1859.
4. Mai FM, Merskey H. Briquet's treatise on hysteria. Arch Gen Psychiatry 1980;37:1401-5.
5. Mai FM, Merskey H. Briquet's concept of hysteria: an historical perspective. Can J Psychiatry 1981;26:57-63.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
7. Merskey H. Analysis of hysteria. 2nd ed. Glasgow: Bell & Bain; 1995. p 184.
8. Kendell R. The distinction between mental and physical illness. Br J Psychiatry 2001;178:490-3.
9. Turner M. Psychiatry and the human sciences. Br J Psychiatry 2003;182:472-4.
10. Merskey H. A variable meaning for the concept of disease. J Med Philos 1986;11:215-32.
11. Perley J, Guze S. Hysteria the stability and usefulness of clinical criteria. New Engl J Med 1962;266:421-6.
12. Guze S. The diagnosis of hysteria: what are we trying to do? Am J Psychiatry 1967;124:77-84.
13. Woodruff R. Hysteria: an evaluation of objective diagnostic criteria by the study of women with chronic medical illness. Br J Psychiatry 1968;114:1115-9.
14. WHO. The ICD-10 classification of mental and behavioral disorders. Geneva; WHO; 1992.
15. Escobar J, Waitzkin H, Silver R, Gara M, Holman A. Abridged somatization: a study in primary care. Psychosom Med 1998;60:466-72.
16. Smith GR, Monson R, Ray D. Patients with multiple unexplained symptoms: their characteristics, functional health and health care utilization. Arch Intern Med 1986;146:69-72.
17. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363-7.
18. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional somatic syndromes? J Psychosom Res 2001;51:549-57.
19. Johnson S, De Luca J, Natelson B. Assessing somatization disorder in the chronic fatigue syndrome. Psychosom Med 1996;58:50-7.
20. Butler J, Chalder T, Wessely S. Causal attribution for somatic sensations in patients with chronic fatigue syndrome and their partners. Psychol Med 2001;31:97-105.
21. Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 1993;150:734-41.
22. Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An International study of the relation between somatic symptoms and depression. New Engl J Med 1999;341:1329-35.
23. Simon G, Von Korff M. Somatization and psychiatric disorders in the NIMH Epidemiological Catchment Area (ECA) Study. Am J Psychiatry 1991;48:1494-500.
24. Russo J, Katon W, Sullivan M, Clark M, Buchwald D. Severity of somatization and its relation to psychiatric disorders and personality. Psychosomatics 1994;35:546-56.
25. Cantor C. Phantom illness. Boston (MA): Mariner Books; 1996.
26. Sutherland A, Rodin G. Factitious disorder in a general hospital setting. Psychosomatics 1990;31:392-9.
27. Martin R, Yutzy S. The somatoform disorders. In: Hales R, Yudofsky S, Talbot J. Textbook of psychiatry. Washington (DC): American Psychiatric Press; 1999. p 673-5.
28. Cloninger R-C, Reich T, Guze S. The multifactorial model of disease transmission: III. Familial relations between sociopathy and hysteria (Briquet's syndrome). Br J Psychiatry 1995;127;23-32.
29. Cloninger R-C, Martin R, Guze S, Clayton P. A prospective follow up and family study of somatization in men and women. Am J Psychiatry 1986;143:873-8.
30. Sigvardsson S, Von Knorring AL, Bohman M, Cloninger CR. An adoption study of somatoform disorders. I. The relationship of somatization to psychiatric disability. Arch Gen Psychiatry 1984;41;853-9.
31. Ljungberg L. Hysteria: a clinical prognostic and genetic study. Acta Psychiatr Neurol Scand 1957;32(Suppl 112):1-162.
32. Torgersen S. Genetics of somatoform disorders. Arch Gen Psychiatry 1986;43:502-5.
33. Slater E. The thirty-fifth Mandley lecture: Hysteria 311. J Ment Sci 1961;107:359-81.
34. Shields J. Genetic studies of hysterical disorders. In: Roy A, editor. Hysteria. New York: John Wiley; 1982. p 41-56.
35. Slater E. Diagnosis of hysteria. BMJ 1965;1:1395-9.
36. Merskey H, Buhrich N. Hysteria and organic brain disease. Br J Med Psychol 1975;48:359-66.
37. Roy A. Hysteria: a case note study. Can J Psychiatry 1979;24:157-60.
38. Ludwig A. Hysteria: a neurobiological theory. Arch Gen Psychiatry 1972;27:771-7.
39. Flor-Henry P, Fromm-Auch D, Tapper M, Schopflocher D. A neuropsychological study of the stable syndrome of hysteria. Biol Psychiatry 1981;16;601-26.
40. Almgren P-E, Nordgren L, Skantze H. A retrospective study of operationally defined hysterics. Br J Psychiatry 1978;132:67-73.
41. Niemi PM, Portin R, Aalto S, Hakala M, Karlsson H. Cognitive functioning in severe somatization a pilot study. Acta Psychiatr Scand 2002;106:461-3.
42. Meyer BU, Britton TC, Benecke R, Bischoff C, Machetanz J, Conrad B. Motor responses evoked by magnetic brain stimulation in psychogenic limb weakness. J Neurol 1992;239:251-5.
43. Rief W, Shaw R, Fichter M. Elevated levels of physiologic arousal and Cortisol in patients with somatization syndrome. Psychosom Med 1998;60:198-203.
44. Kristal-Boneh E, Melamed S, Kushnir T, Froom P, Harari G, Ribak J. Association between somatic symptoms and 24-hour ambulatory blood pressure levels. Psychosom Med 1998;60:616-9.
45. Mechanic D. The concept of illness behaviour. J Chronic Dis 1972;15:189-94.
46. Munford P, Liberman R. Behaviour therapy of hysterical disorders. In: Roy A, editor. Hysteria. New York: John Wiley; 1982. p 287-303.
47. Kellner R. Somatization: theories and research. J Nerv Ment Dis 1990;178:150-60.
48. Escobar J, Canino G. Unexplained physical complaints: psychopathology and epidemiological correlates. Br J Psychiatry 1989;154(Suppl 4):24-7.
49. Kirmayer LJ, Young A. Culture and somatization: clinical, epidemiological and ethnographic perspectives. Psychosom Med 1998;60:420-30.
50. Fink P, Sorensen L Engberg M, Holm M, Munk-Jorgensen P. Somatization in primary care. Psychosomatics 1999;40:330-8.
51. Kroenke K, Spitzer R. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 1998;60:150-5.
52. Lieb R, Zimmermann P, Friis RH, Hofler M, Tholen S, Wittchen HU. The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective-longitudinal community study. Eur Psychiatry 2002;17:321-31.
53. Stern J, Murphy M, Bass C. Personality disorders in patients with somatization disorder: a controlled study. Br J Psychiatry 1993;163:787-9.
54. Hudziak J, Boffeli T, Kriesman JJ, Battaglia MM, Stanger C, Guze SB. A clinical study of the relation between borderline personality disorder to Briquet's syndrome, somatization disorder, antisocial personality disorder and substance abuse disorder. Am J Psychiatry 1996;153:1598-606.
55. Craig TK, Drake H, Mills K, Boardman P. The South London Somatisation Study. II. Influence of stressful life events, and secondary gain. Br J Psychiatry 1994;165:248-58.
56. Sifheos P. The prevalence of alexithymia in psychosomatic patients. Psychother Psychosom 1973;22:255-62.
57. De Gucht V, Heiser W. Alexithymia and somatization: a quantitative review of the literature. J Psychosom Res 2003;54:425-34.
58. Gelder M, Mayou R, Geddes J. Psychiatry. 2nd ed. Oxford (UK): Oxford University Press; 1999. p 217-9.
59. Escobar JI, Bumham MA, Karno M, Forsythe A, Golding JM. Somatization in the community. Arch Gen Psychiatry 1987;44:713-8.
60. Demers M. Frequent users of ambulatory health care in Quebec: the case of doctor-shoppers. CMAJ 1995;153:37-42.
61. Mai F. "Hysteria" in clinical neurology. Can J Neurol Sci 1995;22:101-21.
62. Petrie K, Sivertsen B, Hysing M, Broadbent E, Moss-Morris R, Eriksen HR, and others. Thoroughly modern worries: the relationship of worries about modernity to reported symptoms, health and medical care utilization. J Psychosom Res 2001;51:395-401.
63. Bass C, Peveler R, House A. Somatoform disorders: severe psychiatric illness neglected by psychiatrist. Br J Psychiatry 2001;179:11-4.
64. Hiller W, Fichter M, Rief W. A controlled study of somatoform disorders including analysis of health care utilization and cost effectiveness. J Psychosom Res 2003;54:369-80.
65. Thomassen R, van Hemert AM, Huyse FJ, van der Mast RC, Hengeveld MW. Somatoform disorders in consultation-liaison psychiatry: a comparison with other mental disorders. Gen Hosp Psychiatry 2003;25:8-13.
66. Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosom Med 2002;64:939-50.
67. Crimlisk HL, Bhatia KP, Cope H, David AS, Marsden D, Ron MA. Patterns of referral in patients with medically unexplained motor symptoms. J Psychosom Res 2000;49:217-9.
68. Fink P. Surgery and medical therapy in persistent somatizing patients. J Psychosom Res 1992;36:439-47.
69. Mayou R, Sharpe M. Treating medically unexplained medical symptoms. BMJ 1997;315:561-2.
70. Sharpe M, Carson A. "Unexplained" somatic symptoms, functional syndromes and somatization: do we need a paradigm shift. Ann Intern Med 2001;134:926-30.
71. Smith GR, Rost K, Kashner TM. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients. Arch Gen Psychiatry 1995;52:238-43.
72. Quill T. Somatization disorder: one of medicines' blind spots. JAMA 1985;254;3075-82.
73. Smith C, Monson R, Ray D. Psychiatric consultation in somatization disorder. New Engl J Med 1986;14:1407-13.
74. Salmon P, Peters S, Stanley I. Patients' perceptions of medical explanation for somatization disorders: qualitative analysis. BMJ 1999;318:372-6.
75. Goldberg D, Gask L, O'Dowd T. The treatment of somatization: teaching techniques of reattribution. J Psychosom Res 1989;33:689-95.
76. Ford C. The somatizing disorders: illness as a way of life. New York: Elsevier Biomedical; 1983. p 245.
77. Guthrie E, Moorey J, Margison F, Barker H, Palmer S, McGrath G, and others. Cost-effectiveness of brief psychodynamic-interpersonal therapy in high-utilizers of psychiatric services. Arch Gen Psychiatry 1999;56:519-26.
78. Murphy G. The clinical management of hysteria. JAMA 1982, 247:2559-64.
79. Fink P, Rosendai M, Roft T. The term model a new advanced educational program for general practitioners in the treatment of functional somatic syndromes. J Psychosom Res 2002;2:317-8.
80. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000;9:205-15.
81. Sharpe M, Peveler R, Mayou R. The psychological therapy of patients with functional somatic syndromes. J Psychosom Res 1992;6:515-29.
82. Kuhlwein K. The cognitive treatment of depression in cognitive behaviour therapy: a guide for the practicing clinician. In: Simos G, editor. Hove (UK): Brunner-Routledge; 2002. p 3-48.
83. Speckens AEM, van Hemert AM, Spinhoven P, Hawton KE, Bolk JH, Rooijmans HGM. Cognitive behavior therapy for medically unexplained physical symptoms: a randomized controlled trial. BMJ 1995:1328-32.
84. Lidbeck J. Group therapy for somatization disorders in general practice: effectiveness of a short cognitive-behavioral treatment model. Acta Psychiatr Scand 1997;196:14-24.
85. Escobar JI, Gara MA. Treatment of somatization in primary care. Clinical trial of cognitive-behavioral therapy for somatization disorder. Study identification number 60265-01A2. Piscataway (NJ): University of Medicine and Dentistry of New Jersey; 2003. Available: www.clinicaltrials.gov.
86. Gaarder K, Montgomery P. Clinical biofeedback. Baltimore (MD): Williams & Wilkins; 1979. p 107-22.
87. Peters S, Stanley I, Rose M, Kaney S, Salmon P. A randomized controlled trial of group aerobic exercise in primary care patients with persistent unexplained physical symptoms. Fam Pract 2002;19:665-74.
88. O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K. Efficacy of antidepressants for physical symptoms: a critical review of the literature. J Fam Pract 1999;48:980-90.
89. Phillips K, Albertini R, Rasmussen S. A randomized placebo-controlled trial of fluoxetine in body dysmorphophobic disorder. Arch Gen Psychiatry 2002;59:381-8.
90. Okugawa G, Yagi A, Kusaka H, Kinoshita T. Paroxetine for treatment of somatization disorder. J Neuropsychiatry CUn Neurosci 2002;14:464-5.